Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

Take Solutions Ltd

₹ 42.84.85%
07 Jan – close price
🔗takesolutions.com•BSE: 532890•NSE: TAKE
Market Cap₹ 633 Cr.
Current Price₹ 42.8
High / Low₹ 42.9
Stock P/E69.7
Book Value₹ 1.55
Dividend Yield0.00 %
ROCE18.0 %
ROE16.7 %
Face Value₹ 1.00
Sales₹ 0.00 Cr.
OPMnull %
Mar Cap₹ 633 Cr.

ABOUT

Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]

KEY POINTS

Business Overview:[1]Singapore-based TAKE Solutions Pte Limited holds a 52.90% stake in TSL, serving as the holding company. TSL specializes in Life Sciences and Supply Chain Management, providing comprehensive services in clinical development and specific offerings in supply chain. The company is involved in clinical trials, generics support, including bio-availability & bioequivalent studies, regulatory filing, and pharmacovigilance.

Also present in buckets:
Aggressive Growth TriggersCapacity Expansion And ProductsRed Flags And Poor Performance

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.Syngene Intl.656.7556.5626479.200.1967.10-36.76910.602.2013.523746.8027.57468.2067.105.597.310.12
2.Indegene520.1028.0712512.060.38102.1011.34804.2017.0924.803041.0018.91445.80102.104.3614.190.04
3.Suven Life Scie.173.42–3948.330.00-77.31-55.740.92-64.20-86.965.87-3637.82-211.89-77.3114.02-78.900.00
4.Vimta Labs617.6036.942757.350.1619.9217.04101.8520.1925.22383.7734.9274.6519.926.6115.640.02
5.Fabtech Tech.195.5915.89868.930.0028.11449.02121.48106.8121.98326.6711.8731.6928.11–9.110.22
6.Take Solutions42.7969.68632.700.00-0.6253.680.00–17.960.00–9.08-0.6327.5513.430.00
7.Bilcare78.24–184.210.00-23.32-15.39178.20-11.671.10756.724.30-22.15-12.360.41-3.531.48
–Median: 9 Co.173.4246.75868.930.00.5311.34101.8512.8413.52326.678.29.080.534.977.310.04

Quarterly Results

Standalone figures in ₹ crores

Dec 2022Dec 2023Dec 2024Jun 2023Jun 2024Jun 2025Mar 2023Mar 2024Mar 2025Sep 2022Sep 2023Sep 2024Sep 2025
Sales
12.750.000.005.420.900.0014.790.000.0016.780.000.000.00
Expenses
13.461.510.764.410.612.0212.087.940.7014.271.080.900.28
Operating Profit
-0.71-1.51-0.761.010.29-2.022.71-7.94-0.702.51-1.08-0.90-0.28
Other Income
1.240.711.93-0.34-47.940.012.05-192.775.69-0.130.13-26.56-0.03
Profit before tax
0.21-1.080.940.16-47.82-2.164.01-200.894.782.05-1.44-27.63-0.46
Tax %
66.67%331.48%0.00%112.50%0.13%0.00%-2.74%0.30%0.00%19.02%-24.31%-0.22%34.78%
Net Profit
0.08-4.650.94-0.02-47.88-2.174.12-201.494.781.66-1.10-27.57-0.62
EPS in Rs
0.01-0.310.06-0.00-3.24-0.150.28-13.620.320.11-0.07-1.86-0.04

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
26.0225.8923.5718.842.4421.962.4710.7218.0056.235.420.900.00
Expenses
22.3724.4518.3622.4418.6435.8319.3817.5931.3553.3714.942.953.76
Operating Profit
3.651.445.21-3.60-16.20-13.87-16.91-6.87-13.352.86-9.52-2.05-3.76
Other Income
22.1912.8015.6422.0532.8134.3526.0815.32-459.923.63-192.27-66.897.60
Interest
2.410.110.403.081.070.170.490.360.300.680.740.750.72
Depreciation
5.380.740.190.800.800.801.741.571.231.110.720.050.02
Profit before tax
18.0513.3920.2614.5714.7419.516.946.52-474.804.70-203.25-69.743.10
Net Profit
17.1111.3218.2314.4215.2517.407.747.79-477.174.29-207.25-69.742.93
EPS in Rs
1.400.921.491.081.031.180.520.53-32.260.29-14.01-4.710.19
Dividend Payout %
70.13%106.01%65.88%92.37%155.17%85.00%0.00%0.00%0.00%0.00%0.00%0.00%–

Compounded Profit Growth

10 Years:-1%
5 Years:6%
3 Years:26%
TTM:132%

Compounded Sales Growth

10 Years:-29%
5 Years:-18%
3 Years:-63%
TTM:-100%

Return on Equity

10 Years:-11%
5 Years:-32%
3 Years:-23%
Last Year:17%

Stock Price CAGR

10 Years:-13%
5 Years:-6%
3 Years:23%
1 Year:169%

Balance Sheet

Standalone figures in ₹ crores

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
12.0012.0012.0113.3214.7914.7914.7914.7914.7914.7914.7914.7914.79
Reserves
308.07304.24306.70504.69754.74747.66751.03760.28283.65287.9880.6210.978.19
Borrowings
0.000.0072.770.000.000.003.850.002.391.820.000.000.00
Other Liabilities
11.298.8022.3516.037.1511.816.6211.2010.9414.1123.775.915.91
Total Liabilities
331.36325.04413.83534.04776.68774.26776.29786.27311.77318.70119.1831.6728.89
Fixed Assets
2.050.630.484.603.863.075.974.433.242.120.110.010.00
Gross Block
43.1142.7942.355.405.455.479.929.9910.0210.020.170.03–
Accumulated Depreciation
41.0642.1641.870.801.592.403.955.566.797.900.060.02–
CWIP
0.000.002.160.000.000.000.000.000.000.000.000.000.00
Investments
284.38234.38330.39359.92413.87511.72517.32516.78154.68242.56101.870.000.00
Other Assets
44.9390.0380.80169.52358.95259.47253.00265.06153.8574.0217.2031.6628.89
Total Assets
331.36325.04413.83534.04776.68774.26776.29786.27311.77318.70119.1831.6728.89

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
36.98-2.55-10.77-32.96-24.0212.91-14.91-2.6632.5826.89-4.48-19.51
Cash from Investing Activity
-18.6955.39-91.88-23.57-87.92-111.9021.7913.42-40.19-22.37-1.0222.21
Cash from Financing Activity
-23.00-11.9660.5357.88239.40-28.45-8.26-0.25-1.11-0.84-0.23-0.04
Net Cash Flow
-4.7140.87-42.121.36127.46-127.44-1.3810.51-8.723.69-5.732.66

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
36.3342.5857.7661.61136.13106.871,034.4180.6987.190.000.000.00
Inventory Days
––––––––––––
Days Payable
––––––––––––
Cash Conversion Cycle
36.3342.5857.7661.61136.13106.871,034.4180.6987.190.000.000.00
Working Capital Days
302.86394.32-731.701,958.4826,942.683,456.0333,992.297,838.991,844.47241.86-1,163.025,406.06
ROCE %
6.31%4.24%4.40%3.95%2.44%2.46%0.97%-0.90%0.50%3.57%-4.68%17.96%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters
53.41%53.41%53.41%53.41%53.41%53.41%53.41%53.41%53.41%53.41%53.34%5.19%
FIIs
0.13%0.13%0.13%0.00%0.00%0.02%0.00%0.00%0.00%0.00%0.00%0.00%
DIIs
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.00%0.00%
Public
46.44%46.45%46.46%46.57%46.59%46.56%46.58%46.58%46.59%46.58%46.65%94.81%

* The classifications might have changed from Sep'2022 onwards.ℹ️

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

TAKE Solutions Appoints New Statutory Auditors Following Resignation

27th March 2026, 12:51 am

TAKE Solutions Appoints M/s. A. Raghavendra Rao & Associates as Statutory Auditors

27th March 2026, 12:48 am

TAKE Solutions' Statutory Auditor Resigns Over Audit Fee Concerns

25th March 2026, 11:25 pm

TAKE Solutions Closes Trading Window for Q4 FY26 Period

25th March 2026, 10:49 pm

TAKE Solutions Launches AI Health Platform 'Take.Health', Targets $197 Billion Opportunity

25th March 2026, 3:36 pm

Published by Other Websites

External media mentions & references

TAKE Solutions Hits 2% Upper Circuit on New AI Health Platform Launch

25th March 2026, 3:57 pm

Take Solutions Stock Soars 439% on AI Healthcare Platform Ambition

9th March 2026, 9:57 pm

Haryana Govt Bans Banks Over ₹590 Cr Fraud; IDFC First, AU SFB Hit

23rd February 2026, 7:59 am

TAKE Solutions Bets on AI for India's $197B Healthcare Market

11th February 2026, 9:59 pm

TAKE Solutions Bets Big on India's $197B Preventive Health Market with AI Clinics

11th February 2026, 8:39 pm

News Articles

Editorial & research coverage

TAKE Solutions Launches AI Clinics: High Stakes in Preventive Health
TAKE Solutions Launches AI Clinics: High Stakes in Preventive Health

10th February 2026, 9:16 pm

Take Solutions Surges to 52-Week High! Multibagger Gains Continue Despite Zero Revenue & Promoter Exit?
Take Solutions Surges to 52-Week High! Multibagger Gains Continue Despite Zero Revenue & Promoter Exit?

3rd December 2025, 8:36 am

Documents

Announcements

Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

31 Dec - CFO Vedamirtham Venkatesan and director Cecily Dheepa resigned effective 31 December 2025.

Announcement under Regulation 30 (LODR)-Resignation of Director

31 Dec - Vedamirtham Venkatesan resigned as Whole Time Director and CFO; Cecily Dheepa resigned as Non-Executive Director, effective 31 Dec 2025.

Closure of Trading Window

29 Dec - Trading window closed from Jan 1, 2026 for insiders ahead of Dec 31, 2025 results.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

23 Dec - TAKE Solutions to build AI diagnostic and preventive care platform targeting India’s USD 197bn market.

Announcement under Regulation 30 (LODR)-Change in Registered Office Address

18 Dec - Board approved shifting registered office in Chennai to Anna Nagar East, effective 18 Dec 2025.

Annual Reports

Financial Year 2025

(from bse)

Financial Year 2024

(from bse)

Financial Year 2023

(from bse)

Financial Year 2022

(from bse)

Financial Year 2021

(from bse)

Financial Year 2020

(from bse)

Financial Year 2019

(from bse)

Financial Year 2018

(from bse)

Financial Year 2017

(from bse)

Financial Year 2016

(from bse)

Financial Year 2015

(from bse)

Financial Year 2014

(from bse)

Financial Year 2013

(from bse)

Financial Year 2012

(from bse)

Financial Year 2011

(from bse)

Credit Ratings

Rating update

21 Mar 2023 from care

Rating update

26 Dec 2022 from care

Rating update

24 Dec 2021 from care

Rating update

8 Dec 2021 from care

Rating update

8 Dec 2021 from care

Rating update

17 Aug 2021 from care

Concalls

Aug 2021

Transcript

Jun 2021

Transcript

Feb 2021

Transcript

Dec 2020

Transcript

Sep 2020

Transcript

Oct 2019

Transcript

Aug 2019

Transcript

May 2019

Transcript

Mar 2019

Transcript

Feb 2019

Transcript

Feb 2019

Transcript

Aug 2018

Transcript

May 2018

Transcript

Feb 2018

Transcript

Nov 2017

Transcript

Nov 2017

Transcript

Aug 2017

Transcript

May 2017

Transcript

Jan 2017

Transcript

Dec 2016

Transcript

Oct 2016

Transcript

Feb 2016

PPT

Stock Analysis

Description

  1. Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services.

Key Growth Triggers

  1. TAKE Solutions is embarking on a strategic initiative to develop an AI-powered Diagnostic & Preventive Care Platform, aiming to tap into India's rapidly expanding USD 197 billion preventive healthcare market by 2030. This move targets digital-first healthcare with AI for early detection and predictive diagnostics. The plan aims to strengthen technology leadership and explore scalable opportunities.

Order Book

  1. Currently no data available for Order Book.

Key Red Flags

  1. Company's statutory auditors have repeatedly flagged material uncertainties regarding its ability to continue as a going concern due to pending litigations and unpaid statutory dues.
  2. The company faced significant promoter stake churn throughout 2025, with several entities divesting stakes.
  3. Personnel changes, including CFO and director resignations, add to the prevailing uncertainty.
  4. Historically high working capital days have been a concern.

Key Dates To Watch

  1. Board meeting for Q3 FY26 results expected after January 1, 2026.

Corporate Announcements

26th Mar 26
Impact Rating: 5
Following the resignation of its previous auditors, TAKE Solutions' Board of Directors has approved the appointment of M/s. A. Raghavendra Rao & Associates.
26th Mar 26
Impact Rating: 4
TAKE Solutions' board has approved and recommended the appointment of M/s. A. Raghavendra Rao & Associates as Statutory Auditors, effective March 26, 2026, to fill a vacancy caused by prior resignation.
25th Mar 26
Impact Rating: 6
TAKE Solutions Limited announced that its statutory auditor, M/s. Venkat and Rangaa LLP, has tendered its resignation effective March 25, 2026. The auditor cited constraints related to audit fees, noting remuneration was not commensurate with the business's size and reporting requirements.
25th Mar 26
Impact Rating: 6
TAKE Solutions Limited announces trading window closure from April 1, 2026, for promoters, directors, and key personnel. This is to comply with SEBI's insider trading rules, pending the declaration of Q4 FY26 audited financial results.
25th Mar 26
Impact Rating: 7
TAKE Solutions introduces 'Take.Health', an AI-powered digital health platform for personalized health insights and continuous monitoring, aiming to capture a share of India's $197 billion healthcare opportunity.